Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics

Harm reduction is often defined as value-neutral with regard to drug use and drug users. In this paper Fry, Treloar & Maher argue that to its detriment, harm reduction research (and practice), in its focus on technical skills, evidence and innovation, has failed to articulate an agreed moral fra...

Full description

Saved in:
Bibliographic Details
Published in:Drug and alcohol review Vol. 24; no. 5; pp. 449 - 459
Main Authors: Fry, Craig L., Treloar, Carla, Maher, Lisa
Format: Journal Article
Language:English
Published: Oxford, UK Informa UK Ltd 01-09-2005
Blackwell Publishing Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Harm reduction is often defined as value-neutral with regard to drug use and drug users. In this paper Fry, Treloar & Maher argue that to its detriment, harm reduction research (and practice), in its focus on technical skills, evidence and innovation, has failed to articulate an agreed moral framework. Using case examples from a recent forum on the topic, they make a case for a more ethically engaged harm reduction. Recent debate about ethical issues within harm reduction occurs against similar discussion in public health. The authors explain that crucial issues emerge at intersections between human rights, consumer engagement and applied communitarian ethics. Simon Lenton Editor, Harm Reduction Digest
Bibliography:ark:/67375/WNG-GS7PW0BB-Q
ArticleID:DAR697
istex:1F7F873120D02A35DDB518351F0144C44EC8822D
Drug and Alcohol Review, v.24, no.5, Sept 2005: (449)-459
Craig L. Fry BSc(Hons), Senior Research Fellow, Turning Point Alcohol and Drug Centre, Melbourne, and Fellow, Department of Public Health, University of Melbourne, Melbourne, Australia, Carla Treloar PhD, Research Fellow, National Centre in HIV Social Research, University of New South Wales, Sydney, Australia, Lisa Maher PhD, Associate Professor and Program Head, National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0959-5236
1465-3362
DOI:10.1080/09595230500263905